PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
December 7, 2025Journal of Cerebral Blood Flow & Metabolism0 citations

Editorial to the special issue on extracellular vesicles and mitochondria in CNS function and disease

View Full Paper
KHKazuhide HayakawaDHDirk M. Hermann

Key Points

  • Biomarkers from extracellular vesicles indicate cellular communication and potential therapeutic strategies.
  • CNS injuries disrupt metabolic homeostasis, with mitochondrial dysfunction leading to cell death and inflammation.
  • Assessment of EV-mediated mechanisms provides insights into treatment efficacy and molecular pathways.
  • Clinical trials exploring mitochondrial transplantation for cerebral ischemia highlight unresolved questions in tissue remodeling.

Abstract

Extracellular vesicles (EVs) have emerged as critical mediators of cell-to-cell communication. More recently, a subset of these vesicles has been found to contain mitochondria (EV-Mito). These mitochondria-bearing EVs may act as non-cell-autonomous signaling entities and serve as potential biomarkers for injury and recovery in central nervous system (CNS) pathophysiology. Mitochondria play a vital role in regulating cellular respiration, metabolism, and overall tissue function. In the context of CNS injury or disease, mitochondrial dysfunction can disrupt metabolic homeostasis, leading to cell death and inflammation. Consequently, restoring mitochondrial function represents a key therapeutic target with strong translational potential. This special issue of JCBFM presents a multidisciplinary collection of high-impact reviews and original research articles. These contributions cover a broad spectrum—from basic studies on EV-mediated mechanisms in CNS disorders and the molecular pathways underlying intercellular mitochondrial transfer, to therapeutic applications of EVs and mitochondrial transplantation in cellular and animal models. The issue also highlights the latest clinical trial developments assessing the feasibility of EV and mitochondrial transplantation in cerebral ischemia. Collectively, these articles offer valuable insights into emerging research directions and underscore the many unresolved questions that remain—particularly regarding the quantitative thresholds required for treatment efficacy and the molecular mechanisms driving beneficial tissue remodeling.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Hayakawa et al. (2025) studied this question.

synapsesocial.com/papers/694020ee2d562116f28fb043https://doi.org/10.1177/0271678x251400466
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Extracellular vesicles and mitochondria in central nervous system diseases2025 · 4 citations
  2. 2Mitochondrial extracellular vesicles between pathology and regeneration2026
  3. 3Targeting Mitochondrial Dynamics via EV Delivery in Regenerative Cardiology: Mechanistic and Therapeutic Perspectives2025 · 17 citations
  4. 4Advancing MSC-EV Therapies: Harnessing Preconditioning and Mito-EVs to Tackle Neuroinflammation and Neurodegeneration2026
  5. 5Mesenchymal Stromal Cells and Extracellular Vesicles: A Novel Therapeutic Paradigm for Mitochondrial Dysfunctions2026 · 1 citations